# Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

> **NCT07685457** · NA · RECRUITING · sponsor: **LucasBio** · enrollment: 6 (estimated)

## Conditions studied

- BKV Infection
- CMV Infection
- EBV Infection

## Interventions

- **BIOLOGICAL:** LB-DTK-MV

## Key facts

- **NCT ID:** NCT07685457
- **Lead sponsor:** LucasBio
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-10
- **Primary completion:** 2027-05-20
- **Final completion:** 2027-05-20
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685457, "Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*